The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-07-17
DOI
10.1038/s41598-018-29332-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression
- (2017) Antonio Agostini et al. Oncotarget
- SMG-1 inhibition by miR-192/-215 causes epithelial-mesenchymal transition in gastric carcinogenesis via activation of Wnt signaling
- (2017) Xiaojing Zhang et al. Cancer Medicine
- Clinical relevance of circulating cell-free microRNAs in ovarian cancer
- (2016) Koji Nakamura et al. Molecular Cancer
- The Structure and Clinical Roles of MicroRNA in Colorectal Cancer
- (2016) Linwensi Zhu et al. Gastroenterology Research and Practice
- Prognostic value of microRNA-9 in cancers: a systematic review and meta-analysis
- (2016) Han Sun et al. Oncotarget
- Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features
- (2015) M. Zuberi et al. Clinical & Translational Oncology
- MicroRNAs in Ovarian Cancer
- (2015) Betina Katz et al. HUMAN PATHOLOGY
- The miR-200 Family: Versatile Players in Epithelial Ovarian Cancer
- (2015) Goda Muralidhar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells
- (2015) Anamaria Brozovic et al. Molecular Oncology
- Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival
- (2015) Nikiforos-Ioannis Kapetanakis et al. Oncotarget
- Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer
- (2014) Wei-na Wan et al. Diagnostic Pathology
- Clinically Relevant microRNAs in Ovarian Cancer
- (2014) Shu Zhang et al. MOLECULAR CANCER RESEARCH
- miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma
- (2013) H.W.Z. Khella et al. CARCINOGENESIS
- miRNA Landscape in Stage I Epithelial Ovarian Cancer Defines the Histotype Specificities
- (2013) E. Calura et al. CLINICAL CANCER RESEARCH
- miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition
- (2013) Chaoyang Sun et al. JNCI-Journal of the National Cancer Institute
- Normalizing to GADPH jeopardises correct quantification of gene expression in ovarian tumours – IPO8 and RPL4 are reliable reference genes
- (2013) Zuzana Kolkova et al. Journal of Ovarian Research
- Comparison of Analysis Tools for miRNA High Throughput Sequencing Using Nerve Crush as a Model
- (2013) Raghu Prasad Rao Metpally et al. Frontiers in Genetics
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- microRNA and the pathogenesis of ovarian cancer – a new horizon for molecular diagnostics and treatment?
- (2012) Jan Dominik Kuhlmann et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- MicroRNA and cancer
- (2012) Martin D. Jansson et al. Molecular Oncology
- Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
- (2011) Sergio Marchini et al. LANCET ONCOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- The Role of MicroRNAs in Human Liver Cancers
- (2011) Chiara Braconi et al. SEMINARS IN ONCOLOGY
- microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer
- (2011) YEUNPO CHIANG et al. Experimental and Therapeutic Medicine
- Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development
- (2010) Flavia Pichiorri et al. CANCER CELL
- MicroRNA: Biogenesis, Function and Role in Cancer
- (2010) Leigh-Ann MacFarlane et al. CURRENT GENOMICS
- MicroRNAs in the Pathogenesis of Lung Cancer
- (2010) Xin Wu et al. Journal of Thoracic Oncology
- miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation
- (2010) Valentina Boni et al. MOLECULAR CANCER THERAPEUTICS
- A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
- (2009) Xiaoxia Hu et al. GYNECOLOGIC ONCOLOGY
- Repertoire of microRNAs in Epithelial Ovarian Cancer as Determined by Next Generation Sequencing of Small RNA cDNA Libraries
- (2009) Stacia K. Wyman et al. PLoS One
- MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
- (2008) N. Yang et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search